FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Exela Pharma Sciences Potassium Acetate Injection Recall

Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, M…

Exela Pharma Sciences LLC · Lenoir, NC

Risk level
Class III
Reported by FDA
Sep 23, 2020
Recall ID
D-1585-2020
Check your lot numberHow we source this data

Summary

Exela Pharma Sciences recalled Potassium Acetate Injection starting May 5, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1585-2020 on Sep 23, 2020. Reason: Short Fill. Status: Terminated.

Why it was recalled

Short Fill

Product description

Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4

Lot numbers, UPCs & expiration codes

Lot #P0000471, Catalog #2020TS002, Exp Date: 04/2021

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1585-2020
Classification
Class III
Status
Terminated
Recall initiated
May 5, 2020
FDA report date
Sep 23, 2020
Quantity
23,775 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Exela Pharma Sciences LLC

Original FDA data

Every field from FDA enforcement report D-1585-2020, exactly as published.

Show all FDA fields
City
Lenoir
State
NC
Status
Terminated
Country
United States
Event ID
86288
Address
1245 Blowing Rock Blvd
Code information
Lot #P0000471, Catalog #2020TS002, Exp Date: 04/2021
Postal code
28645-3618
Report date
Sep 23, 2020
Product type
Drugs
Recall number
D-1585-2020
Classification
Class III
Recalling firm
Exela Pharma Sciences LLC
Product quantity
23,775 vials
Termination date
Jan 14, 2022
Reason for recall
Short Fill
Voluntary / mandated
Voluntary: Firm initiated
Product description
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
May 5, 2020
Initial firm notification
Letter
Center classification date
Sep 14, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1585-2020, published Sep 23, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls